LEADER 01379oam  2200481 a 450 
001 9910693367803321
005 20090909135629.0
035   $a(CKB)5470000002361856
035   $a(GPO)apn2005-010599
035   $a(OCoLC)55085925
035   $a(EXLCZ)995470000002361856
100   $a20040423g20049999  ua             0
101 0 $aeng
135   $aur|||   |||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDrugs@FDA$b[electronic resource]
210   $aWashington D.C. $cU.S. Food and Drug Administration, Center for Drug and Evaluation Research
300   $aTitle from home page (viewed on July 18, 2005).
517 3 $aDrugs at FDA
606   $aDrugs$zUnited States
606   $aDrugs, Nonprescription$zUnited States
606   $aDrug approval$zUnited States
606   $aPharmaceutical Preparations
606   $aDrug Approval
607   $aUnited States
615  0$aDrugs
615  0$aDrugs, Nonprescription
615  0$aDrug approval
615  2$aPharmaceutical Preparations.
615  2$aDrug Approval.
712 02$aCenter for Drug Evaluation and Research (U.S.)
801  0$bDLC
801  1$bDLC
801  2$bOCLCQ
801  2$bSBH
801  2$bPSM
801  2$bGPO
906   $aBOOK
912   $a9910693367803321
996   $aDrugs@FDA$93155172
997   $aUNINA